Skip to main content

Table 8 Assigning type of SAE through causality

From: Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol

Relationship

Description

SAE type

Definitely

There is clear evidence to suggest a causal relationship and other possible contributing factors can be ruled out

SAR

Probable

There is evidence to suggest a causal relationship and the influence of other factors is unlikely

SAR

Possible

There is some evidence to suggest a causal relationship (for example, because the event occurs within a reasonable time after administration of the trial medication). However, the influence of other factors may have contributed to the event (for example, the child’s clinical condition, other concomitant treatments)

SAR

Unlikely

There is little evidence to suggest that there is a causal relationship (for example, the event did not occur within a reasonable time after administration of the trial medication). There is another reasonable explanation for the event (for example, the child’s clinical condition, other concomitant treatment)

Unrelated SAE

Unrelated

There is no evidence of any causal relationship

Unrelated SAE